Welcome! I opened a speculative position in August 2018, but it was early February (like you and LM) when I increased my position and have been steadily adding since then. Back in February I expected to have interim cancer results by now, so while it is a little frustrating this was delayed......I am glad leronlimab hasn't failed in cancer (or anywhere for that matter). IMO a delay is much more acceptable given all the positive data points and indications leronlimab looks to have potential in. We will get clarity soon and many things point to leronlimab being a blockbuster drug.

Best of luck!